ArticleClinical & experimental ophthalmology2022

Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion.

Paul Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.